These results indicate that MMP-7 and MMP-10 not only differentiate cervical cancer from dysplasia and healthy controls but also reflect disease stage, supporting their potential clinical application as sensitive and specific serum biomarkers. The gene discussed is MMP7; the disease is cervical carcinoma.